168 related articles for article (PubMed ID: 16764142)
1. Making an earlier diagnosis of ADPKD: implications for the treatment of hypertension.
Perrone R; Miskulin DC
Nephrol News Issues; 2006 Jun; 20(7):32, 35-6. PubMed ID: 16764142
[No Abstract] [Full Text] [Related]
2. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?
Perrone RD; Miskulin DC
Am J Kidney Dis; 2005 Sep; 46(3):557-9. PubMed ID: 16129219
[No Abstract] [Full Text] [Related]
3. A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease.
Ulusoy S; Ozkan G; Orem C; Kaynar K; Koşucu P; Kiriş A
Ren Fail; 2010; 32(8):913-7. PubMed ID: 20722556
[TBL] [Abstract][Full Text] [Related]
4. Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD).
Cadnapaphornchai MA; Fick-Brosnahan GM; Duley I; Johnson AM; Strain JD; DeGroff CG; Schrier RW
Contemp Clin Trials; 2005 Apr; 26(2):211-22. PubMed ID: 15837441
[TBL] [Abstract][Full Text] [Related]
5. Identification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study.
McGovern AP; Jones S; van Vlymen J; Saggar AK; Sandford R; de Lusignan S
BMC Nephrol; 2014 Nov; 15():182. PubMed ID: 25412767
[TBL] [Abstract][Full Text] [Related]
6. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
[TBL] [Abstract][Full Text] [Related]
7. Optimal care of autosomal dominant polycystic kidney disease patients.
Schrier RW
Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
[TBL] [Abstract][Full Text] [Related]
8. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and autosomal dominant polycystic kidney disease.
Schrier RW
Am J Kidney Dis; 2011 Jun; 57(6):811-3. PubMed ID: 21601126
[No Abstract] [Full Text] [Related]
10. Therapeutic interventions for autosomal dominant polycystic kidney disease.
Edelstein CL
Nephrol News Issues; 2008 Mar; 22(3):25-6. PubMed ID: 18372677
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
[TBL] [Abstract][Full Text] [Related]
12. Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.
Steinman TI
Nephrol Dial Transplant; 2008 Feb; 23(2):431-3. PubMed ID: 18065782
[No Abstract] [Full Text] [Related]
13. Research review.
Pham T
CANNT J; 2000; 10(3):55-6. PubMed ID: 11799585
[No Abstract] [Full Text] [Related]
14. [Use of angiotensin converting enzyme inhibitors in nephrology].
Stefanović V; Ivić M; Bogićević M
Srp Arh Celok Lek; 1994; 122(7-8):228-30. PubMed ID: 17974394
[TBL] [Abstract][Full Text] [Related]
15. Progress in blood pressure control in autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Fick-Brosnahan GM; Johnson AM; Duley IT; Gabow PA; Schrier RW
Am J Kidney Dis; 2000 Aug; 36(2):266-71. PubMed ID: 10922304
[TBL] [Abstract][Full Text] [Related]
16. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant polycystic kidney disease: time for a change?
Chapman AB
J Am Soc Nephrol; 2007 May; 18(5):1399-407. PubMed ID: 17429048
[TBL] [Abstract][Full Text] [Related]
19. [A 30-year-old woman patient with reno-parenchymatous arterial hypertension].
Estlinbaum T
Praxis (Bern 1994); 2003 Feb; 92(6):244-6. PubMed ID: 12645388
[No Abstract] [Full Text] [Related]
20. Autosomal dominant polycystic kidney disease and hypertension in the aviator.
Fox KA; Rudge FW
Aviat Space Environ Med; 1996 Apr; 67(4):376-8. PubMed ID: 8900993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
